← Open Payments lookup

FOUAD MALIK: Open Payments

NPI 1790093540 · MIDLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,292 in 66 payments from 16 companies in 2025. Trend: 2023 $964 · 2024 $850 · 2025 $1,292

Food & beverage: $1,292
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$321
ABBVIE INC.12$283
Novo Nordisk Inc5$77
GlaxoSmithKline, LLC.4$76
AstraZeneca Pharmaceuticals LP4$74
Exact Sciences Corporation4$69
Otsuka America Pharmaceutical, Inc.3$66
Verona Pharma, Inc.3$63
Xeris Pharmaceuticals, Inc.3$63
Gilead Sciences, Inc.2$49

Products named: CAPLYTA, VRAYLAR, Wegovy, TRELEGY ELLIPTA, Cologuard Collection Kit, REXULTI, Ohtuvayre, GVOKE HYPOPEN.

Industry payments across MI — which companies pay providers there.